Skip to main content
. Author manuscript; available in PMC: 2013 Sep 1.
Published in final edited form as: Bioorg Med Chem. 2012 Jul 6;20(17):5247–5253. doi: 10.1016/j.bmc.2012.06.046

Figure 2.

Figure 2

Dose-response showing I− influx in 3F508-CFTR cells treated for 24 h with triazolobithiazoles 13–15 or corr-4a and stimulated by a cAMP agonist (forskolin) and potentiator (genistein) (S.E., n=4).